Financial News

Financial Report: Lilly

Trulicity revenues up 20% in the quarter, driven by increased demand.

By: Contract Pharma

Contract Pharma Staff

Lilly 2Q Revenues: $5.5 billion (-2%) 2Q Earnings: $1.4 billion (+6%) YTD Revenues: $11.4 billion (+6%) YTD Earnings: $2.9 billion (-48%) Comments: Trulicity revenue was $1.2 billion, up 20% in the quarter, driven by increased demand, partially offset by lower realized prices. Humalog revenue decreased 18% to $555.1 million. Revenue in the U.S. decreased 29 driven primarily by lower realized prices, reflecting a favorable Medicaid adjustment in 2Q19 and an unfavorable Managed...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters